Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2016

Pharma News, 2016

Nichi-Iko Pharmaceutical Co., Ltd. Announces Results Of Tender Offer To Purchase All Of The Outstanding Shares Of Common Stock Of Sagent Pharmaceuticals, Inc.
Nichi-Iko Pharmaceutical Co., Ltd. Announces Results Of Tender Offer To Purchase All Of The Outstanding Shares Of Common Stock Of Sagent Pharmaceuticals, Inc.
Nichi-Iko Pharmaceutical Co.
FDA: Test Blood Donations for Zika Virus
FDA: Test Blood Donations for Zika Virus
As a further safety measure against the emerging Zika virus outbreak, today the U.
Ecological consequences of amphetamine pollution in urban streams
Ecological consequences of amphetamine pollution in urban streams
Millbrook, NY -- Public Release.
New method of cancer immunotherapy developed
New method of cancer immunotherapy developed
SAN FRANCISCO, Aug.
Boosting brain protein alleviates Alzheimer's symptoms, study says
Boosting brain protein alleviates Alzheimer's symptoms, study says
LA JOLLA, Calif.
FDA Accepts Clovis Oncology’s New Drug Application for Rucaparib for Priority Review for the Treatment of Advanced Mutant BRCA Ovarian Cancer
FDA Accepts Clovis Oncology’s New Drug Application for Rucaparib for Priority Review for the Treatment of Advanced Mutant BRCA Ovarian Cancer
 BOULDER, CO, USA -- August 23, 2016-- Clovis Oncology, Inc.
Amgen Provides Update On Status Of Parsabiv™ (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA)
Amgen Provides Update On Status Of Parsabiv™ (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA)
THOUSAND OAKS, CA, USA I August 24, 2016 I Amgen (Nasdaq.
Pharmaceutical company brings more investment to Greenville
Pharmaceutical company brings more investment to Greenville
A pharmaceutical development and manufacturing company announced Wednesday it is renovating an existing building to triple the capacity of its stability storage space.
Sleep hormone may suppress breast cancer growth
Sleep hormone may suppress breast cancer growth
Suggesting a link between lack of sleep and increased risk of breast cancer, a new study has found that melatonin, a hormone produced in the human brain at night to regulate sleep cycles, appears to s...
Chinese scientists discover molecules to repair organs
Chinese scientists discover molecules to repair organs
XIAMEN, Aug.
U.K. finds big issues with Pfizer Hospira plant in India
U.K. finds big issues with Pfizer Hospira plant in India
Pfizer was well aware that a Hospira plant in India had a history of issues when it acquired the sterile injectable drug maker last year for $15 billion.
Pfizer to Buy Antibiotics From AstraZeneca for $725 Million
Pfizer to Buy Antibiotics From AstraZeneca for $725 Million
Pfizer Inc.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand